Pulmatrix, Inc. (PULM) Stock Tumbling in Aftermarket Following Reverse Stock Split Announcement.
Maria Masood
February 25, 2022
Pulmatrix, Inc. (PULM) is a late-stage biotherapeutics company engaged in the development of novel inhaled therapeutics for pulmonary and non-pulmonary disorders. The company utilizes its